Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 34, 2022 - Issue 8
131
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Antiretroviral treatment adherence and mental disorders: observational case-control study in people living with HIV in Spain

ORCID Icon, , , , &
Pages 1064-1072 | Received 15 Nov 2020, Accepted 07 Jun 2021, Published online: 24 Jun 2021

References

  • Alcohol, tabaco y drogas ilegales en España. (2015). Observatorio Español de la Droga y las Toxicomanías.
  • Amanor-Boadu, S., Hipolito, M. S., Rai, N., McLean, C. K., Flanagan, K., Hamilton, F. T., Oji, V., Lambert, S. F., Le, H. N., Kapetanovic, S., & Nwulia, E. A. (2016). Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans. World Journal of Psychiatry, 6(1), 128–135. https://doi.org/10.5498/wjp.v6.i1.128
  • Arseniou, S., Arvaniti, A., & Samakouri, M. (2014). HIV infection and depression. Psychiatry and Clinical Neurosciences, 68(2), 96–109. https://doi.org/10.1111/pcn.12097
  • Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112(3), 178–193. https://doi.org/10.1016/j.drugalcdep.2010.06.014
  • Azmach, N. N., Hamza, T. A., & Husen, A. A. (2019). Socioeconomic and demographic statuses as determinants of adherence to antiretroviral treatment in HIV infected patients: A systematic review of the literature. Current HIV Research, 17(3), 161–172. https://doi.org/10.2174/1570162x17666190919130229
  • Beyer, J. L., Taylor, L., Gersing, K. R., & Krishnan, K. R. (2007). Prevalence of HIV infection in a general psychiatric outpatient population. Psychosomatics, 48(1), 31–37. https://doi.org/10.1176/appi.psy.48.1.31
  • Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016). Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine (Baltimore), 95(15), e3361. https://doi.org/10.1097/md.0000000000003361
  • Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., & Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721–728. https://doi.org/10.1001/archpsyc.58.8.721
  • Blank, M. B., Himelhoch, S., Walkup, J., & Eisenberg, M. M. (2013). Treatment considerations for HIV-infected individuals with severe mental illness. Current HIV/AIDS Reports, 10(4), 371–379. https://doi.org/10.1007/s11904-013-0179-3
  • Boussari, O., Subtil, F., Genolini, C., Bastard, M., Iwaz, J., Fonton, N., Etard, J. F., & Ecochard, R. (2015). Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality. BMC Medical Research Methodology, 15(1), 10. https://doi.org/10.1186/1471-2288-15-10
  • Carrico, A. W. (2010). Elevated suicide rate among HIV-positive persons despite benefits of antiretroviral therapy: Implications for a stress and coping model of suicide. American Journal of Psychiatry, 167(2), 117–119. https://doi.org/10.1176/appi.ajp.2009.09111565
  • Carrico, A. W., Johnson, M. O., Morin, S. F., Remien, R. H., Charlebois, E. D., Steward, W. T., & Chesney, M. A. (2007). Correlates of suicidal ideation among HIV-positive persons. AIDS, 21(9), 1199–1203. https://doi.org/10.1097/QAD.0b013e3281532c96
  • Chambers, L. A., Rueda, S., Baker, D. N., Wilson, M. G., Deutsch, R., Raeifar, E., & Rourke, S. B. (2015). Stigma, HIV and health: A qualitative synthesis. BMC Public Health, 15(1), 848. https://doi.org/10.1186/s12889-015-2197-0
  • Chi, B. H., Cantrell, R. A., Zulu, I., Mulenga, L. B., Levy, J. W., Tambatamba, B. C., Reid, S., Mwango, A., Mwinga, A., Bulterys, M., Saag, M. S., & Stringer, J. S. (2009). Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. International Journal of Epidemiology, 38(3), 746–756. https://doi.org/10.1093/ije/dyp004
  • Cohen, M. A., & Gorman, J. M. (Eds.). (2008). Comprehensive textbook of AIDS psychiatry. Oxford University Press.
  • Cornejo, A., Díaz, A., Díez, M., & Valín, E. R. J. B. e. s. (2015). Vigilancia epidemiológica del VIH/sida. Situación en Europa y en España, 2013, 22(18), 249–256.
  • Costiniuk, C. T., Saneei, Z., Salahuddin, S., Cox, J., Routy, J. P., Rueda, S., Abdallah, S. J., Jensen, D., Lebouche, B., Brouillette, M. J., Klein, M., Szabo, J., Frenette, C., Giannakis, A., & Jenabian, M. A. (2019). Cannabis consumption in people living with HIV: Reasons for use, secondary effects, and opportunities for health education. Cannabis and Cannabinoid Research, 4(3), 204–213. https://doi.org/10.1089/can.2018.0068
  • Disney, E., Kidorf, M., Kolodner, K., King, V., Peirce, J., Beilenson, P., & Brooner, R. K. (2006). Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. Journal of Nervous & Mental Disease, 194(8), 577–583. https://doi.org/10.1097/01.nmd.0000230396.17230.28
  • Ferrando, L., Bobes, J., Gibert, J., Soto, M., & Soto, O. (1998). 1.1. MINI Entrevista Neuropsiquiátrica Internacional (MINI International Neuropsychiatric Interview, MINI).
  • Gallego, L., Barreiro, P., & Lopez-Ibor, J. J. (2011). Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection. AIDS Reviews, 13(3), 171–179.
  • Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58(2), 181–187. https://doi.org/10.1097/QAI.0b013e31822d490a
  • Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B., & Donovan, D. M. (2017). Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS and Behavior, 21(4), 1138–1148. https://doi.org/10.1007/s10461-016-1584-6
  • Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52(2), 180–202. https://doi.org/10.1097/QAI.0b013e3181b18b6e
  • Kacanek, D., Jacobson, D. L., Spiegelman, D., Wanke, C., Isaac, R., & Wilson, I. B. (2010). Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the nutrition for healthy living study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53(2), 266–272. https://doi.org/10.1097/QAI.0b013e3181b720e7
  • Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013). Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. Journal of the International AIDS Society, 16(3 Suppl 2), 18640. https://doi.org/10.7448/ias.16.3.18640
  • Knobel, H., Alonso, J., Casado, J. L., Collazos, J., Gonzalez, J., Ruiz, I., Kindelan, J. M., Carmona, A., Juega, J., & Ocampo, A. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. AIDS, 16(4), 605–613. https://doi.org/10.1097/00002030-200203080-00012
  • Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdottir, T. B., Richter, C., Sprangers, M. A., & Nieuwkerk, P. T. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12(1), 142. https://doi.org/10.1186/preaccept-1453408941291432
  • Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. C. (1997). The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry, 12(5), 224–231. https://doi.org/10.1016/S0924-9338(97)83296-8
  • Levi-Minzi, M. A., & Surratt, H. L. (2014). HIV stigma among substance abusing people living with HIV/AIDS: Implications for HIV treatment. AIDS Patient Care and STDs, 28(8), 442–451. https://doi.org/10.1089/apc.2014.0076
  • Lima, V. D., Harrigan, R., Bangsberg, D. R., Hogg, R. S., Gross, R., Yip, B., & Montaner, J. S. (2009). The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(5), 529–536. https://doi.org/10.1097/QAI.0b013e31819675e9
  • Majer, J. M., Komer, A. C., & Jason, L. A. (2015). Psychiatric severity and HIV-risk sexual behaviors among persons with substance use disorders. Journal of Dual Diagnosis, 11(1), 3–11. https://doi.org/10.1080/15504263.2014.990802
  • Meade, C. S., Bevilacqua, L. A., & Key, M. D. (2012). Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV. AIDS and Behavior, 16(8), 2267–2271. https://doi.org/10.1007/s10461-012-0203-4
  • Mimiaga, M. J., Safren, S. A., Dvoryak, S., Reisner, S. L., Needle, R., & Woody, G. (2010). “We fear the police, and the police fear us”: Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care, 22(11), 1305–1313. https://doi.org/10.1080/09540121003758515
  • Ngo-Giang-Huong, N., Jourdain, G., Amzal, B., Sang-a-gad, P., Lertkoonalak, R., Eiamsirikit, N., Tansuphasawasdikul, S., Buranawanitchakorn, Y., Yutthakasemsunt, N., Mekviwattanawong, S., McIntosh, K., & Lallemant, M. (2011). Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysis. PLoS One, 6(11), e27427. https://doi.org/10.1371/journal.pone.0027427
  • Ogundipe, O. A., Olagunju, A. T., & Adeyemi, J. D. (2015). Suicidal ideation among attendees of a West African HIV clinic. Archives of Suicide Research, 19(1), 103–116. https://doi.org/10.1080/13811118.2014.915776
  • Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodriguez, E., Warren, M. R., & Vejo, J. (2011). Adherence to highly active antiretroviral therapy (HAART): A meta-analysis. AIDS and Behavior, 15(7), 1381–1396. https://doi.org/10.1007/s10461-011-9942-x
  • Parsons, J. T., Rosof, E., & Mustanski, B. (2008). The temporal relationship between alcohol consumption and HIV-medication adherence: A multilevel model of direct and moderating effects. Health Psychology, 27(5), 628–637. https://doi.org/10.1037/a0012664
  • Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. https://doi.org/10.7326/0003-4819-133-1-200007040-00004
  • Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A. (2019). Mental health and HIV/AIDS: The need for an integrated response. AIDS, 33(9), 1411–1420. https://doi.org/10.1097/qad.0000000000002227
  • Safren, S. A., O’Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., Otto, M. W., & Mayer, K. H. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28(1), 1–10. https://doi.org/10.1037/a0012715
  • Sendino, R., Álvares, E., Brime, B., Llorens, N., Ruiz, A., & Sánchez, E. J. O. E. d. L. D. y. L. T. M. d. S. y. S. S. (2016). Informe 2016: alcohol, tabaco y drogas ilegales en España. 72.
  • Sharifi, V., Amin-Esmaeili, M., Hajebi, A., Motevalian, A., Radgoodarzi, R., Hefazi, M., & Rahimi-Movaghar, A. (2015). Twelve-month prevalence and correlates of psychiatric disorders in Iran: The Iranian mental health survey, 2011. Archives of Iranian Medicine, 18(2), 76–84. https://doi.org/10.15182/aim.004
  • Sheehan, D. M., De La Cruz, Y., Ramírez-Ortiz, D., Swendeman, D., Muñoz-Laboy, M., Duncan, D. T., Cano, M., Devieux, J. G., & Trepka, M. J. (2021). A qualitative study of antiretroviral therapy adherence interruptions among young Latino men who have sex with men with HIV: Project D.A.I.L.Y. AIDS Care, 33(7): 962-969. https://doi.org/10.1080/09540121.2021.1874277
  • Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33. quiz 34–57.
  • Shuper, P. A., Joharchi, N., Irving, H., Fletcher, D., Kovacs, C., Loutfy, M., Walmsley, S. L., Wong, D. K., & Rehm, J. (2016). Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals. AIDS Care, 28(8), 954–962. https://doi.org/10.1080/09540121.2016.1158396
  • Sikkema, K. J., Watt, M. H., Drabkin, A. S., Meade, C. S., Hansen, N. B., & Pence, B. W. (2010). Mental health treatment to reduce HIV transmission risk behavior: A positive prevention model. AIDS and Behavior, 14(2), 252–262. https://doi.org/10.1007/s10461-009-9650-y
  • Skalski, L. M., Watt, M. H., MacFarlane, J. C., Proeschold-Bell, R. J., Stout, J. E., & Sikkema, K. J. (2015). Mental health and substance use among patients in a North Carolina HIV clinic. North Carolina Medical Journal, 76(3), 148–155. https://doi.org/10.18043/ncm.76.3.148
  • Socias, M. E., & Milloy, M. J. (2018). Substance use and adherence to antiretroviral therapy: What is known and what is unknown. Current Infectious Disease Reports, 20(9), 36. https://doi.org/10.1007/s11908-018-0636-7
  • Springer, S. A., Dushaj, A., & Azar, M. M. (2012). The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS and Behavior, 16(8), 2119–2143. https://doi.org/10.1007/s10461-012-0212-3
  • Tegger, M. K., Crane, H. M., Tapia, K. A., Uldall, K. K., Holte, S. E., & Kitahata, M. M. (2008). The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care and STDs, 22(3), 233–243. https://doi.org/10.1089/apc.2007.0092
  • Tsuyuki, K., & Surratt, H. L. (2015). Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations. AIDS and Behavior, 19(5), 869–881. https://doi.org/10.1007/s10461-014-0969-7
  • Unit, W. H. O. M. o. S. A. (2014). Global status report on alcohol and health, 2014. World Health Organization.
  • Vidot, D. C., Lerner, B., & Gonzalez, R. (2017). Cannabis use, medication management and adherence among persons living with HIV. AIDS and Behavior, 21(7), 2005–2013. https://doi.org/10.1007/s10461-017-1782-x
  • Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2003). Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care and STDs, 17(4), 179–186. https://doi.org/10.1089/108729103321619782
  • Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2004). Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care, 16(4), 501–506. https://doi.org/10.1080/09540120410001683420

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.